Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

Delayed Data
As of Jul 21
 -0.61 / -1.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 42.00, with a high estimate of 50.00 and a low estimate of 38.00. The median estimate represents a +5.55% increase from the last price of 39.79.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Haemonetics Corp. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.55%
Growthannually 4.58%


Growthquarterly -6.92%
Growthannually 0.59%
Key to the earnings and sales forecast charts.